The immediate and drastic cut in National Institutes of Health funding for biomedical research by changing the indirect cost reimbursement rate to research sites, including many universities, will destabilize America’s standing as the worldwide leader in driving scientific and medical innovation and discoveries that save lives and keep our country safe.
The removal of these resources from the websites of CDC and other health agencies is deeply concerning and creates a dangerous gap in scientific information and data to monitor and respond to disease outbreaks.
Read IDSA’s updated summary of the Senate hearings to consider the nomination of Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services.
The Clinical Practice Guidelines are the latest from the American Thoracic Society, the Centers for Disease Control and Prevention, European Respiratory Society and Infectious Diseases Society of America.
The National Institute of Allergy and Infectious Diseases has taken a major step to support the infectious diseases workforce by increasing interim paylines, or funding cutoff points, for research grants for fiscal year 2025.
The eight awarded institutions have created stewardship programs led by infectious diseases-trained physicians and pharmacists that advance science in antimicrobial resistance.
The American Society for Microbiology and IDSA are excited to announce a partnership to develop an annual conference on antimicrobial resistance.
IDSA and PIDS congratulate the 316 adult physicians and 43 pediatric physicians who matched today in infectious diseases. They are joining a vital and meaningful specialty that offers many pathways and opportunities throughout their careers.
The Centers for Medicare and Medicaid Services released its calendar year 2025 Medicare Physician Fee Schedule Final Rule on November 1, including a new add-on code for infectious diseases developed and advocated for by IDSA.
The HIV Medicine Association is pleased to recognize three members during IDWeek 2024 for their contributions to advancing the field of HIV medicine.
The HIV Medicine Association is pleased to announce the election of Colleen Kelley, MD, MPH, FIDSA, as the new chair of its Board of Directors. HIVMA is dedicated to addressing health disparities and health inequities in its mission to end the HIV epidemic.
The Infectious Diseases Society of America is pleased to announce Tina Tan, MD, FIDSA, FPIDS, FAAP, as the Society’s new president beginning Oct. 20.